Pfizer: Between Hope, Despair, And A 5.7% Yield


  • Pfizer has underperformed the S&P 500, healthcare stocks, and high-yield stocks since 2013.
  • The company’s weight-loss pill has faced setbacks and is not competitive with leading drugs from other pharmaceutical companies.
  • Pfizer is adapting by focusing on a once-daily version of the weight-loss pill and exploring mergers to strengthen its position in the market.

Chancellor George Osborne Visits Pharmaceutical Company Pfizer

Dan Kitwood/Getty Images News


It’s time to talk about Pfizer (NYSE:PFE). Since the 1970s, the company has returned 12,500%, helping countless investors reach their financial goals.

When adding the many blockbuster drugs it had in the past, it’s truly

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABBV, DHR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Test Drive iREIT© on Alpha For FREE (for 2 Weeks)

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial.

And this offer includes a 2-Week FREE TRIAL plus Brad Thomas’ FREE book.

Leave a Reply

Your email address will not be published. Required fields are marked *